Hydrogen Nanozyme in Lab Tests Reduced Joint Damage in Arthritis
Spontaneous hydrogen-releasing nanoenzyme alleviates osteoarthritis via oxidative stress reduction and mitochondrial dysfunction reversal
Research hubs: Musculoskeletal System
This research was done on cells or tissue in a lab, not in people or animals.
- Evidence type
- Laboratory study (cells or tissue)
- Authors
- Qi Wang, Minyi Zhang, Weihao Jiang, Dejian Li, Beijie Qi, Shi Shi, Shuo Shi, Chengqing Yi
- Journal
- Journal of Nanobiotechnology
- Year
- 2025
- PMID
- 41076526
- Study Type
- Mouse
- Delivery
- Gas (Sustained Release)
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 18 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
Hydrogen-releasing nanozymes combat osteoarthritis by reducing oxidative stress, restoring mitochondria, and slowing cartilage damage.
Key Finding
Hydrogen-releasing nanoparticles reduced oxidative stress and reversed mitochondrial dysfunction in mouse models of osteoarthritis, while promoting cartilage matrix synthesis and slowing disease progression.
Summary
Researchers created a special nanoparticle (a tiny engineered particle) that releases hydrogen gas and tested it in mice with osteoarthritis, a degenerative joint disease. The treatment reduced harmful molecules called free radicals, improved damaged cellular structures called mitochondria, and slowed cartilage breakdown, suggesting hydrogen gas may help protect joints from osteoarthritis damage.
Practical Takeaway
This early-stage animal study suggests hydrogen gas may help address some of the cellular damage underlying osteoarthritis, but much more research is needed before any conclusions can be drawn for human use. The study was conducted only in mice and used a specialized nanoparticle delivery system, not hydrogen water as typically consumed.
Abstract (excerpt)
Osteoarthritis (OA), a chronic and degenerative joint disease, has become increasingly prevalent due to the aging population, posing a significant societal burden. However, despite progress, effective therapeutic options for osteoarthritis remain limited. In OA, chronic inflammation mediates…